Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Patient Saf. 2022 Jul 21;18(6):611–616. doi: 10.1097/PTS.0000000000001050

Table 3.

Characteristics of Voluntary Reporting System Adverse Events (Type and Harm Codes)

Event Type N (total n=21)
Falls 6
Skin/Tissue 1
Medication/IV 8
*ifosfamide, methotrexate, potassium/potassium chloride, busulfan, carboplatin, etoposide/etoposdie phosphate, mesna, dextrose 5%, 0.45% NaCl, Voriconazole, fenofibrate/fenofirbrate micronized, famotidine, prednisone
Blood Product/Transfusion 4
Line/Tube/Drain 2
Harm Code Definition N (total n=21)
A Circumstances or events that have the capacity to cause error 4
B An error that did not reach the patient 1
C An error that reached the patient but did not cause harm 8
D An error that reached the patient and required monitoring or intervention to confirm that it resulted in no harm to the patient 2
E Temporary harm to the patient and required intervention 6
F Temporary harm to the patient and required initial or prolonged hospitalization 0
G Permanent patient harm 0
H Intervention required to sustain life 0
I Patient death 0
*

medications listed in event descriptions submitted to the Voluntary Safety Reporting System